These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 22880883

  • 1. Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function.
    Gziri MM, Debiève F, DE Catte L, Mertens L, Barrea C, VAN Calsteren K, Han SN, Heyns L, Amant F.
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1465-8. PubMed ID: 22880883
    [Abstract] [Full Text] [Related]

  • 2. Fetal rat hearts do not display acute cardiotoxicity in response to maternal Doxorubicin treatment.
    Gziri MM, Pokreisz P, De Vos R, Verbeken E, Debiève F, Mertens L, Janssens SP, Amant F.
    J Pharmacol Exp Ther; 2013 Sep; 346(3):362-9. PubMed ID: 23792410
    [Abstract] [Full Text] [Related]

  • 3. Incremental diagnostic yield of pediatric cardiac assessment after fetal echocardiography in the offspring of women with congenital heart disease: a prospective study.
    Thangaroopan M, Wald RM, Silversides CK, Mason J, Smallhorn JF, Sermer M, Colman JM, Siu SC.
    Pediatrics; 2008 Mar; 121(3):e660-5. PubMed ID: 18310185
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus?
    Framarino-Dei-Malatesta M, Sammartino P, Napoli A.
    BMC Cancer; 2017 Nov 21; 17(1):777. PubMed ID: 29162041
    [Abstract] [Full Text] [Related]

  • 6. Tei index to assess fetal cardiac performance in fetuses at risk for fetal inflammatory response syndrome.
    Letti Müller AL, Barrios Pde M, Kliemann LM, Valério EG, Gasnier R, Magalhães JA.
    Ultrasound Obstet Gynecol; 2010 Jul 21; 36(1):26-31. PubMed ID: 20131338
    [Abstract] [Full Text] [Related]

  • 7. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
    Ekstein S, Nir A, Rein AJ, Perles Z, Bar-Oz B, Salpeter L, Algur N, Weintraub M.
    J Pediatr Hematol Oncol; 2007 Jul 21; 29(7):440-4. PubMed ID: 17609620
    [Abstract] [Full Text] [Related]

  • 8. Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines.
    Guimaraes-Filho F, Tan D, Braga J, Rodrigues A, Waib P, Matsubara B.
    Am J Cardiol; 2007 Oct 15; 100(8):1303-6. PubMed ID: 17920375
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis of cardiac anomalies in offspring of women with congenital heart disease: is fetal echocardiography enough?
    Allan LD.
    Nat Clin Pract Cardiovasc Med; 2008 Sep 15; 5(9):522-3. PubMed ID: 18648337
    [Abstract] [Full Text] [Related]

  • 10. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG, Oğuz A, Tunaoğlu FS, Karadeniz C, Gökçora N, Elbeg S.
    Pediatr Blood Cancer; 2005 Apr 15; 44(4):370-7. PubMed ID: 15602715
    [Abstract] [Full Text] [Related]

  • 11. Speckle-Tracking Echocardiography to Detect Cardiac Toxicity in Children Who Received Anthracyclines During Pregnancy.
    Avilès A, Nambo MJ, Huerta-Guzmàn J, Neri N, Cleto S.
    Clin Lymphoma Myeloma Leuk; 2016 Jan 15; 16(1):1-4. PubMed ID: 26549215
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
    Moon TJ, Miyamoto SD, Younoszai AK, Landeck BF.
    Cardiol Young; 2014 Oct 15; 24(5):854-65. PubMed ID: 24044518
    [Abstract] [Full Text] [Related]

  • 13. Determination of the myocardial performance index in deteriorating grades of intrauterine growth restriction and its link to adverse outcomes.
    Bhorat IE, Bagratee JS, Pillay M, Reddy T.
    Prenat Diagn; 2015 Mar 15; 35(3):266-73. PubMed ID: 25394754
    [Abstract] [Full Text] [Related]

  • 14. Fetal cardiac dysfunction in preterm premature rupture of membranes.
    Romero R, Espinoza J, Gonçalves LF, Gomez R, Medina L, Silva M, Chaiworapongsa T, Yoon BH, Ghezzi F, Lee W, Treadwell M, Berry SM, Maymon E, Mazor M, DeVore G.
    J Matern Fetal Neonatal Med; 2004 Sep 15; 16(3):146-57. PubMed ID: 15590440
    [Abstract] [Full Text] [Related]

  • 15. Fetal cardiac biometry and function in HIV-infected pregnant women exposed to HAART therapy.
    De la Calle M, Rodriguez R, Deirós L, Bartha JL.
    Prenat Diagn; 2015 May 15; 35(5):453-5. PubMed ID: 25512023
    [Abstract] [Full Text] [Related]

  • 16. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.
    van Dalen EC, van der Pal HJ, van den Bos C, Kok WE, Caron HN, Kremer LC.
    Eur J Cancer; 2006 Oct 15; 42(15):2549-53. PubMed ID: 16919450
    [Abstract] [Full Text] [Related]

  • 17. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines.
    Ylänen K, Poutanen T, Savukoski T, Eerola A, Vettenranta K.
    Acta Paediatr; 2015 Mar 15; 104(3):313-9. PubMed ID: 25393922
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW, Richards DA, Boyd A, Hui R, Harnett PR, Meikle SR, Byth K, Stuart K, Clarke JL, Thomas L.
    Eur J Cancer; 2013 Nov 15; 49(16):3396-403. PubMed ID: 23937961
    [Abstract] [Full Text] [Related]

  • 19. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K, Slone T, Lemler M, Leonard D, Cochran C, Bowman WP, Bashore L, Winick N.
    Pediatr Blood Cancer; 2015 Jan 15; 62(1):123-7. PubMed ID: 25176022
    [Abstract] [Full Text] [Related]

  • 20. Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: a pilot study.
    Valensise H, Vasapollo B, Novelli GP, Larciprete G, Romanini ME, Arduini D, Galante A, Romanini C.
    Ultrasound Obstet Gynecol; 2001 Nov 15; 18(5):450-5. PubMed ID: 11844163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.